The Telomere deprotection response is functionally distinct from the Genomic DNA damage response

Molecular Cell

Volumn 51, Issue 2, 2013, Pages 141-155

  Cesare, AnthonyJ ^a   Hayashi, MakotoT ^a   Crabbe, Laure ^a   Karlseder, Jan ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2; GENOMIC DNA; PROTEIN P53;

ARTICLE; CELL DIVISION; CONTROLLED STUDY; DAUGHTER CELL; DNA DAMAGE; ENZYME PHOSPHORYLATION; EPIGENETICS; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TELOMERE DEPROTECTION; TELOMERE HOMEOSTASIS;

BLOTTING, WESTERN; CELL AGING; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL PROLIFERATION; DNA DAMAGE; DNA REPLICATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; G2 PHASE; GENOME, HUMAN; HUMANS; IMMUNOPRECIPITATION; MITOSIS; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 2; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

ATAXIA TELANGIECTASIA;

EID: 84880509389     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.06.006     Document Type: Article

References (34)

1. Armanios M., Blackburn E.H. The telomere syndromes. Nat. Rev. Genet. 2012, 13:693-704.
2. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645.
3. Buscemi G., Zannini L., Fontanella E., Lecis D., Lisanti S., Delia D. The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage. Curr. Biol. 2009, 19:874-879.
4. Carneiro T., Khair L., Reis C.C., Borges V., Moser B.A., Nakamura T.M., Ferreira M.G. Telomeres avoid end detection by severing the checkpoint signal transduction pathway. Nature 2010, 467:228-232.
5. Celli G.B., de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 2005, 7:712-718.
6. Celli G.B., Denchi E.L., de Lange T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 2006, 8:885-890.
7. Cesare A.J., Karlseder J. A three-state model of telomere control over human proliferative boundaries. Curr. Opin. Cell Biol. 2012, 24:731-738.
8. Cesare A.J., Kaul Z., Cohen S.B., Napier C.E., Pickett H.A., Neumann A.A., Reddel R.R. Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat. Struct. Mol. Biol. 2009, 16:1244-1251.
9. Chapman J.R., Barral P., Vannier J.B., Borel V., Steger M., Tomas-Loba A., Sartori A.A., Adams I.R., Batista F.D., Boulton S.J. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 2013, 49:858-871.
10. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97:527-538.
11. Crabbe L., Cesare A.J., Kasuboski J.M., Fitzpatrick J.A., Karlseder J. Human telomeres are tethered to the nuclear envelope during postmitotic nuclear assembly. Cell Rep 2012, 2:1521-1529.
12. de Lange T. How shelterin solves the telomere end-protection problem. Cold Spring Harb. Symp. Quant. Biol. 2010, 75:167-177.
13. Deckbar D., Birraux J., Krempler A., Tchouandong L., Beucher A., Walker S., Stiff T., Jeggo P., Löbrich M. Chromosome breakage after G2 checkpoint release. J.Cell Biol. 2007, 176:749-755.
14. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448:1068-1071.
15. Deng C., Zhang P., Harper J.W., Elledge S.J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995, 82:675-684.
16. Dimitrova N., Chen Y.C., Spector D.L., de Lange T. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature 2008, 456:524-528.
17. Escribano-Díaz C., Orthwein A., Fradet-Turcotte A., Xing M., Young J.T., Tkáč J., Cook M.A., Rosebrock A.P., Munro M., Canny M.D., et al. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol. Cell 2013, 49:872-883.
18. Gong Y., de Lange T. A Shld1-controlled POT1a provides support for repression of ATR signaling at telomeres through RPA exclusion. Mol. Cell 2010, 40:377-387.
19. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell 1999, 97:503-514.
20. Hayashi M.T., Cesare A.J., Fitzpatrick J.A., Lazzerini-Denchi E., Karlseder J. A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest. Nat. Struct. Mol. Biol. 2012, 19:387-394.
21. Jackson S.P., Durocher D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol. Cell 2013, 49:795-807.
22. Karlseder J., Smogorzewska A., de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002, 295:2446-2449.
23. Karlseder J., Hoke K., Mirzoeva O.K., Bakkenist C., Kastan M.B., Petrini J.H., de Lange T. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2004, 2:E240.
24. Kaul Z., Cesare A.J., Huschtscha L.I., Neumann A.A., Reddel R.R. Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Rep. 2012, 13:52-59.
25. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574.
26. Lim D.S., Kim S.T., Xu B., Maser R.S., Lin J., Petrini J.H., Kastan M.B. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 2000, 404:613-617.
27. O'Sullivan R.J., Kubicek S., Schreiber S.L., Karlseder J. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat. Struct. Mol. Biol. 2010, 17:1218-1225.
28. Okamoto K., Bartocci C., Ouzounov I., Diedrich J.K., Yates J.R., Denchi E.L. A two-step mechanism for TRF2-mediated chromosome-end protection. Nature 2013, 494:502-505.
29. Pampalona J., Frías C., Genescà A., Tusell L. Progressive telomere dysfunction causes cytokinesis failure and leads to the accumulation of polyploid cells. PLoS Genet. 2012, 8:e1002679.
30. Peuscher M.H., Jacobs J.J. DNA-damage response and repair activities at uncapped telomeres depend on RNF8. Nat. Cell Biol. 2011, 13:1139-1145.
31. Stansel R.M., de Lange T., Griffith J.D. T-loop assembly invitro involves binding of TRF2 near the 3' telomeric overhang. EMBO J. 2001, 20:5532-5540.
32. Thanasoula M., Escandell J.M., Suwaki N., Tarsounas M. ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres. EMBO J. 2012, 31:3398-3410.
33. Waldman T., Kinzler K.W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 1995, 55:5187-5190.
34. Wu J., Chen Y., Lu L.Y., Wu Y., Paulsen M.T., Ljungman M., Ferguson D.O., Yu X. Chfr and RNF8 synergistically regulate ATM activation. Nat. Struct. Mol. Biol. 2011, 18:761-768.